Search

We are excited to announce the return of our bitesize liver pathology sessions for a second year. These will take place on Monday afternoons from 4.30-5.30pm, held via zoom. This years' topics have been selected to cover different areas of the field of liver pathology, and are based on delegate feedback from last year.

These one hour webinars are aimed at senior registrars predominantly, but may also be of interest to SAS doctors and consultants who report liver biopsies occasionally as part of their everyday work. The aim is to provide attendees with the opportunity to view example digital slides before each session, followed by case based discussions by an expert in the field. There will also be the opportunity for speakers to provide hints and tips to aid in diagnosis and interpretation, and for delegates to pose questions to the speakers to enhance their understanding.

CPD Credits: 6 (for all sessions)

In order to detect and identify amyloid, biopsy slides must be properly prepared, stained and examined. This requires precise technique, correct equipment and professional expertise, or amyloid deposits may be missed or incorrectly diagnosed. We will look at amyloid staining, correctly diagnosing amyloid in tissues and the associated laboratory techniques.

Five sessions comprising mainly lectures and some practical activities to assist with some elements of the IBMS Clinical Biochemistry and Haematology and Hospital Transfusion Practice Specialist Diplomas.

Series of free scientific webinars

Various stands planned to promote the IBMS and our profession.

These one day events have put been put together in association with the NHSCSP Cervical Cancer Audit Management Group to help guide both new and experienced Hospital Based Programme Co-ordinators (HBPCs) through the various aspects of the job role and update them on recent changes within the NHSCSP.
Day one is aimed specifically at those new to post and while experienced HBPCs are welcome to attend some aspects of this day may appear a little straightforward.
Day two is aimed more at those who have been in post and will concentrate on the invasive cancer audit and disclosure with an update on recent results and sessions relating to disclosure and medico legal aspects of the audit